On December 31, 2024 InnoCan Pharma Corporation closed the transaction and issued 3,177,223 Units at a price of CAD 0.20 per Unit for aggregate gross proceeds of CAD 635,444.60. The Company paid an arm's length finder a cash fee of CAD 13,500 and issued to the finder 67,500 warrants attributable to investors introduced to the Company by the finder within 3 months following such introduction. Each Finder Warrant entitles the Finder to purchase one Common Share at an exercise price of CAD 0.28 for a period of four (4) years from the date of issuance.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1850 CAD | +2.78% |
|
+15.62% | -11.90% |
Dec. 31 | Innocan Pharma Closes Private Placement for $635,444 | MT |
Dec. 30 | InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding | CI |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- InnoCan Pharma Corporation announced that it has received CAD 0.635445 million in funding